Article Versions Notes

Campkin DM, Shimadate Y, Bartholomew B, Bernhardt PV, Nash RJ, Sakoff JA, Kato A, Simone MI. Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy. Molecules. 2022; 27(11):3447. https://doi.org/10.3390/molecules27113447

Campkin, David M., Yuna Shimadate, Barbara Bartholomew, Paul V. Bernhardt, Robert J. Nash, Jennette A. Sakoff, Atsushi Kato, and Michela I. Simone. 2022. "Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy" Molecules 27, no. 11: 3447. https://doi.org/10.3390/molecules27113447

Campkin, D. M., Shimadate, Y., Bartholomew, B., Bernhardt, P. V., Nash, R. J., Sakoff, J. A., Kato, A., & Simone, M. I. (2022). Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy. Molecules, 27(11), 3447. https://doi.org/10.3390/molecules27113447